Literature DB >> 22249559

Primary IgG4-related lymphadenopathy with prominent granulomatous inflammation and reactivation of Epstein-Barr virus.

Emiko Takahashi1, Masaru Kojima, Mizuki Kobayashi, Atsuko Kitamura, Toyoharu Yokoi, Kazuo Hara, Shigeo Nakamura.   

Abstract

We report a unique case of primary IgG4-related lymphadenopathy showing prominent granulomatous inflammation and Epstein-Barr virus (EBV) reactivation. Involved lymph nodes showed an expanded interfollicular zone with prominent granulomatous inflammation, including a predominance of epithelioid macrophages and occasional Langhans multinucleated giant cells. Bundles of spindle cells were also observed. Intermingled with the granulomatous inflammation were numerous mature plasma cells, eosinophils, and neutrophils. The percentage of IgG4+/IgG+ plasma cells was markedly elevated (70%), along with raised serum IgG4 levels. The plasma cells did not show immunoglobulin light-chain restriction. EBV-positive lymphocytes were scattered throughout the paracortical areas. Corticosteroid treatment was very effective. IgG4-related lymphadenopathy has a broad histological spectrum and might be misdiagnosed due to other conditions which morphologically closely resemble it. The correct diagnosis is important in view of the remarkable response to steroid therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249559     DOI: 10.1007/s00428-011-1186-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  8 in total

1.  Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue.

Authors:  G Niedobitek; H Herbst; L S Young; L Brooks; M G Masucci; J Crocker; A B Rickinson; H Stein
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

2.  Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity.

Authors:  C A Moran; S Suster; S L Abbondanzo
Journal:  Hum Pathol       Date:  1997-03       Impact factor: 3.466

Review 3.  IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.

Authors:  Wah Cheuk; John K C Chan
Journal:  Adv Anat Pathol       Date:  2010-09       Impact factor: 3.875

Review 4.  IgG4-related disease: historical overview and pathology of hematological disorders.

Authors:  Yasuharu Sato; Kenji Notohara; Masaru Kojima; Katsuyoshi Takata; Yasufumi Masaki; Tadashi Yoshino
Journal:  Pathol Int       Date:  2010-04       Impact factor: 2.534

5.  Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.

Authors:  Stefan D Dojcinov; Girish Venkataraman; Stefania Pittaluga; Iwona Wlodarska; Jeffrey A Schrager; Mark Raffeld; Robert K Hills; Elaine S Jaffe
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

6.  Inflammatory pseudotumor of lymph nodes: clinicopathologic and immunohistological study of 11 Japanese cases.

Authors:  M Kojima; S Nakamura; K Shimizu; Y Hosomura; Y Ohno; H Itoh; N Yamane; K Yoshida; N Masawa
Journal:  Int J Surg Pathol       Date:  2001-07       Impact factor: 1.271

7.  Lymphadenopathy of IgG4-related sclerosing disease.

Authors:  Wah Cheuk; Hunter K L Yuen; Stephenie Y Y Chu; Edmond K W Chiu; L K Lam; John K C Chan
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

8.  Lymphoplasmacytic infiltrate of regional lymph nodes in Kuttner's tumor (chronic sclerosing sialadenitis): a report of 3 cases.

Authors:  Masaru Kojima; Shuichi Miyawaki; Satoru Takada; Kenji Kashiwabara; Tadahiko Igarashi; Shigeo Nakamura
Journal:  Int J Surg Pathol       Date:  2008-07       Impact factor: 1.271

  8 in total
  4 in total

1.  Perifollicular granulomas with IgG4 plasmacytosis: A case report and review of literature.

Authors:  Li Liang; Jain Zhou; Lei Chen
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

2.  IgG4-Related Lymphadenopathy.

Authors:  Yasuharu Sato; Tadashi Yoshino
Journal:  Int J Rheumatol       Date:  2012-06-10

3.  Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.

Authors:  Berlin Londono-Renteria; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

4.  Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.

Authors:  Koki Ueda; Kazuhiko Ikeda; Kazuei Ogawa; Masumi Sukegawa; Takahiro Sano; Satoshi Kimura; Osamu Suzuki; Yuko Hashimoto; Yasuchika Takeishi
Journal:  J Med Case Rep       Date:  2016-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.